Craig Tendler, J&J Innovative Medicine, on Diversity, Equity and Inclusion in Our Clinical Trials

By developing internal and external clinical research methods focused on inclusive representation, we can build trust between patients and healthcare providers-an essential component of creating a diverse, equitable, and inclusive future.
Hear Craig Tendler, M.D., Vice President, Oncology Clinical Development, Diagnostics & Global Medical Affairs, share his dedication to supporting accessibility in clinical trials and ensuring equity in healthcare outcomes for oncology patients this National Cancer Prevention Month.
Visit ResearchIncludesMe.com to learn more about diversity, equity, and inclusion in clinical trials.